Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03012074
Other study ID # Pro00071569
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2017
Est. completion date May 30, 2020

Study information

Verified date January 2020
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will use mobile health technologies to provide everyday data to help patients and their care providers better understand illness dynamics and develop adaptive approaches to improve health outcomes in diabetes. Specifically, the study will identify strategies to help patients adapt using multiple types of self-generated diabetes-related data and help providers guide patients to better self-manage in real-time, when guidance is needed most.


Description:

The investigators will conduct a mixed-methods exploratory designed study and recruit 60 adult patients (age ≥ 18) with type 2 diabetes who will track relevant clinical data over 6 months. Participants will be asked to use a wireless glucose monitor, a cellular body scale, and a wrist-worn accelerometer, and respond to short bi-weekly text message-based surveys on medication adherence for 6 months. Data generated from the devices will be plotted as trajectories that will allow us to conduct trajectory analyses and identify missing data points and trends leading to attrition, in order to assess the feasibility of having patients engage in this type of self-monitoring for 6 months. A subset of 20 patients will be interviewed via telephone at the end of their 6 month self-monitoring period to discuss their adaptive challenges and successes over the study period. The investigators will present the trajectories of their data during patient interviews using a visual that we will e-mail or postal mail, depending on patient preference. This will facilitate discussion of the challenges participants face in self-management and adaptive practices participants use. Following the 6 months of self-monitoring, we will conduct interviews with health care providers in which the investigators will present the data trajectories and explore ways to achieve continual communication and address real-time challenges with diabetes self-management.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 30, 2020
Est. primary completion date May 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- =18 years old

- able to speak and read English

- diagnosed with type 2 diabetes mellitus

- told by their primary care provider to monitor their blood sugar daily

- owning and using a smart phone

- capable of giving informed consent

- with no pre-existing severe medical condition(s) that would interfere with study participation (e.g., renal failure, severe orthopedic conditions or joint replacement scheduled within 6 months, paralysis, or cancer)

Exclusion Criteria:

- active dementia or psychiatric illness

- reside in a nursing home

- participating in another self-management study

Study Design


Intervention

Behavioral:
Type 2 Diabetes Self-Management
Patients with Type 2 Diabetes

Locations

Country Name City State
United States Duke University School of Nursing Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Explore health care providers' perspectives on using real-time data, by conducting one-time, individual interviews over a 2 month period. Explore ways to achieve continual communication that addresses real-time challenges with diabetes self-management while presenting data trajectories during provider interviews. 2 months
Primary Number of participants with type II diabetes who adhere to using mobile technologies to self-monitor multiple types of diabetes-related data 6 months
Secondary Explore the adaptive challenges of patients self-managing diabetes, using monthly interviews over 6 months. 6 months
Secondary Explore the successes of patients self-managing diabetes, using monthly interviews over 6 months. 6 months
Secondary Change in daily blood glucose levels in patients with diabetes over a 6 month period Data generated from the phone-tethered glucose monitor and plotted as a trajectory over a 6 month period 6 months
Secondary Change in daily weight in patients with diabetes over a 6 month period Data generated from the cellular body scale and plotted as a trajectory over a 6 month period 6 months
Secondary Change in daily physical activity in patients with diabetes over a 6 month period Data generated from the wrist-worn accelerometer and plotted as a trajectory over a 6 month period 6 months
Secondary Medication adherence Survey bi-weekly text message-based surveys on medication adherence over a 6 month period. 6 months
See also
  Status Clinical Trial Phase
Completed NCT03596177 - A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus Phase 2
Completed NCT01728740 - Bioequivalence Study for Acarbose / Metformin FDC Phase 1
Completed NCT02648854 - Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers Phase 1
Recruiting NCT02347020 - Impact of Sleep and Meal Timing on Food Intake Regulation N/A
Completed NCT00577590 - Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM N/A
Completed NCT00094796 - Rosiglitazone to Reverse Metabolic Defects in Diabetes Phase 2
Completed NCT04830969 - Impact of Periodontal Therapy on Patients With Diabetes Phase 2
Completed NCT03112382 - Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus Phase 4
Recruiting NCT01197092 - The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II Phase 2
Completed NCT00649909 - Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients N/A
Terminated NCT00554697 - Diabetes Mellitus Type II and Tissue Oxygenation N/A
Not yet recruiting NCT05957224 - Differences in Postprandial Glucose Changes N/A
Active, not recruiting NCT02088658 - Technology Intensified Diabetes Education Study in African Americans N/A
Completed NCT00081328 - Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Phase 3
Completed NCT00482079 - A Study of MK0431 in Patients With Type 2 Diabetes (0431-010) Phase 2
Recruiting NCT04092738 - ´Sit Less, Move More` at Work: mHealth Intervention on Office Employees With Diabetes Type 2. N/A
Completed NCT02175537 - Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar N/A
Completed NCT01651065 - Micro-Clinic Obesity and Metabolic Risk Prevention Program N/A
Completed NCT00528918 - Comparison of Apidra to Regular Insulin in Hospitalized Patients N/A
Completed NCT00086515 - Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Phase 3